5MU8 | pdb_00005mu8

HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free: 
    0.300 (Depositor), 0.304 (DCC) 
  • R-Value Work: 
    0.211 (Depositor), 0.213 (DCC) 
  • R-Value Observed: 
    0.211 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5MU8

Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history

Literature

Structural Basis of Small-Molecule Aggregate Induced Inhibition of a Protein-Protein Interaction.

Blevitt, J.M.Hack, M.D.Herman, K.L.Jackson, P.F.Krawczuk, P.J.Lebsack, A.D.Liu, A.X.Mirzadegan, T.Nelen, M.I.Patrick, A.N.Steinbacher, S.Milla, M.E.Lumb, K.J.

(2017) J Med Chem 60: 3511-3517

  • DOI: https://doi.org/10.1021/acs.jmedchem.6b01836
  • Primary Citation Related Structures: 
    5MU8

  • PubMed Abstract: 

    A prevalent observation in high-throughput screening and drug discovery programs is the inhibition of protein function by small-molecule compound aggregation. Here, we present the X-ray structural description of aggregation-based inhibition of a protein-protein interaction involving tumor necrosis factor α (TNFα). An ordered conglomerate of an aggregating small-molecule inhibitor (JNJ525) induces a quaternary structure switch of TNFα that inhibits the protein-protein interaction between TNFα and TNFα receptors. SPD-304 may employ a similar mechanism of inhibition.


  • Organizational Affiliation
    • Emerging Science & Innovation, Discovery Sciences, Janssen R&D LLC , La Jolla, California 92121, United States.

Macromolecule Content 

  • Total Structure Weight: 867.17 kDa 
  • Atom Count: 56,305 
  • Modeled Residue Count: 6,955 
  • Deposited Residue Count: 7,632 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Tumor necrosis factor159Homo sapiensMutation(s): 0 
Gene Names: TNFTNFATNFSF2
UniProt & NIH Common Fund Data Resources
Find proteins for P01375 (Homo sapiens)
Explore P01375 
Go to UniProtKB:  P01375
PHAROS:  P01375
GTEx:  ENSG00000232810 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP01375
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
JNI

Query on JNI



Download:Ideal Coordinates CCD File
AB [auth D]
AC [auth h]
BB [auth F]
BC [auth h]
CB [auth F]
AB [auth D],
AC [auth h],
BB [auth F],
BC [auth h],
CB [auth F],
CC [auth j],
DB [auth H],
DC [auth j],
EB [auth H],
EC [auth l],
FB [auth J],
FC [auth n],
GB [auth J],
GC [auth n],
HB [auth L],
HC [auth o],
IB [auth M],
IC [auth p],
JB [auth N],
JC [auth p],
KB [auth P],
KC [auth r],
LB [auth P],
LC [auth r],
MB [auth Q],
MC [auth t],
NB [auth R],
NC [auth t],
OB [auth U],
OC [auth v],
PB [auth V],
PC [auth v],
QB [auth V],
RB [auth X],
SB [auth X],
TB [auth Z],
UB [auth Z],
VB [auth b],
WA [auth A],
WB [auth b],
XA [auth A],
XB [auth d],
YA [auth C],
YB [auth f],
ZA [auth C],
ZB [auth f]
~{N}4-(phenylmethyl)-~{N}4-[2-[3-(2-piperazin-1-ylpyrimidin-5-yl)phenyl]phenyl]pyrimidine-2,4-diamine
C31 H30 N8
FRBABIFCTILEGV-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.00 Å
  • R-Value Free:  0.300 (Depositor), 0.304 (DCC) 
  • R-Value Work:  0.211 (Depositor), 0.213 (DCC) 
  • R-Value Observed: 0.211 (Depositor) 
Space Group: P 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 104.888α = 97.57
b = 118.348β = 94.31
c = 186.747γ = 98.75
Software Package:
Software NamePurpose
XDSdata reduction
XSCALEdata scaling
REFMACrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2017-03-29
    Type: Initial release
  • Version 1.1: 2017-04-12
    Changes: Database references
  • Version 1.2: 2017-05-10
    Changes: Database references
  • Version 1.3: 2019-02-20
    Changes: Advisory, Data collection, Derived calculations
  • Version 1.4: 2024-11-13
    Changes: Data collection, Database references, Structure summary